Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 150, Issue 2, 2004, Pages 156-158

  Kuriakose, Philip ^a   Perveen, Nusrat ^a   Maeda, Koichi ^a   Wiktor, Anne ^a   Van Dyke, Daniel L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; ANAMNESIS; ARTICLE; B CELL LEUKEMIA; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKOCYTOSIS; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; SPLENOMEGALY;

AGED; BONE MARROW; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, B-CELL; LEUKEMIA, PROLYMPHOCYTIC; TRANSLOCATION, GENETIC;

EID: 1842506365     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.09.009     Document Type: Article

References (21)

1. Melo J.V., Catovsky D., Galton D.A. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 63:1986;377-387.
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol. 42:1989;567-584.
3. Matutes E., Owusu-Ankomah K., Morilla R., Garcia Marco J., Houlihan A., Que T.H., Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 8:1994;1640-1645.
4. Brito-Babapulle V., Pittman S., Melo J.V., Pomfret M., Catovsky D. Cytogenetic studies on prolymphocytic leukemia 1. B-cell prolymphocytic leukemia. Hematol Pathol. 1:1987;27-33.
5. Brito-Babapulle V., Garcia-Marco J., Maljaie S.H., Hiorns L., Coignet L., Conchon M., Catovsky D. The impact of molecular cytogenetics on chronic lymphoid leukaemia. Acta Haematol. 98:1997;175-186.
6. Lens D., Matutes E., Catovsky D., Coignet L.J. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia. 14:2000;427-430.
7. Lens D., De Schouwer P.J., Hamoudi R.A., Abdul-Rauf M., Farahat N., Matutes E., Crook T., Dyer M.J. Catovsky D. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 89:1997;2015-2023.
8. Rubnitz J.E., Look A.-T. Molecular genetics of childhood leukemias. J Pediatr Hematol Oncol. 20:1998;1-11.
9. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Accessed July 9, 2003. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
10. Michaux L. B-cell prolymphocytic leukemia (B-PLL). In: Atlas of genetics and cytogenetics in oncology and haematology [Internet]. Accessed July 9, 2003. Available at: http://www.infobiogen.fr/services/chromcancer/Anomalies/BPLL.html.
11. Sole F., Woessner S., Espinet B., Lloveras E., Florensa L., Perez-Losada A., Vila R.M., Besses C., Sans-Sabrafen J. Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 103:1998;43-45.
12. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 79:1982;7837-7841.
13. Bilhou-Nabera C. t(8;14)(q24;q32),t(2;8)(p12;q24),t(8;22)(q24;q11). In: Atlas of genetics and cytogenetics in oncology and haematology [Internet]. Accessed July 9, 2003. Available at: http://www.infobiogen.fr/services/ chromcancer/Anomalies/t0814ID1050.html.
14. Zervos A.-S., Gyuris J., Brent R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. [Erratum: Cell 1994;79: following 388.] Cell. 72:1993;223-232.
15. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318:1985;533-538.
16. Dalla-Favera R., Martinotti S., Gallo R.C., Erikson J., Croce C.-M. Translocation and rearrangements of the c-myc oncogene in human undifferentiated B-cell lymphomas. Science. 219:1983;963-967.
17. Feneux D., Choquet S., de Almeida C., Davi F., Garand R., Valensi F., Leonard C., Merle-Beral H. Cytogenetic studies by FISH on B cell prolymphocytic leukemia. [abstract] Blood. 88:(Suppl. 1):1996;155b.
18. Lens D., Coignet L.J.A., Brito-Babapulle V., Lima C.S.P., Matutes E., Dyer M.J.S., Catovsky D. B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene. Leukemia. 13:1999;873-876.
19. Merchant S., Schlette E., Sanger W., Lai R., Medeiros L.J. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med. 127:2003;305-309.
20. Melo J.V., Catovsky D., Gregory W.M., Galton D.A. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia IV. Analysis of survival and prognostic features. Br J Haematol. 65:1987;23-29.
21. Lorand-Metze I., Oliveira G.B., Aranha F.J. Treatment of prolymphocytic leukemia with cladribine. Ann Hematol. 76:1998;85-86.